Figure 3 | Scientific Reports

Figure 3

From: Profiling of cis-Diol-containing Nucleosides and Ribosylated Metabolites by Boronate-affinity Organic-silica Hybrid Monolithic Capillary Liquid Chromatography/Mass Spectrometry

Figure 3

Relative amounts ratio of cis-diol-containing nucleosides and ribosylated metabolites in (A) lung cancer, (B) colorectal cancer and (C) nasopharyngeal cancer compared to heathy controls. (D) Bar graphs for the distribution of the relative amounts ratio of cis-diol-containing nucleosides and ribosylated metabolites.

Back to article page